234 related articles for article (PubMed ID: 11234909)
1. The effects of vagus nerve stimulation on cognitive performance in patients with treatment-resistant depression.
Sackeim HA; Keilp JG; Rush AJ; George MS; Marangell LB; Dormer JS; Burt T; Lisanby SH; Husain M; Cullum CM; Oliver N; Zboyan H
Neuropsychiatry Neuropsychol Behav Neurol; 2001 Jan; 14(1):53-62. PubMed ID: 11234909
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Rush AJ; Sackeim HA; Marangell LB; George MS; Brannan SK; Davis SM; Lavori P; Howland R; Kling MA; Rittberg B; Carpenter L; Ninan P; Moreno F; Schwartz T; Conway C; Burke M; Barry JJ
Biol Psychiatry; 2005 Sep; 58(5):355-63. PubMed ID: 16139581
[TBL] [Abstract][Full Text] [Related]
3. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
4. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
George MS; Rush AJ; Marangell LB; Sackeim HA; Brannan SK; Davis SM; Howland R; Kling MA; Moreno F; Rittberg B; Dunner D; Schwartz T; Carpenter L; Burke M; Ninan P; Goodnick P
Biol Psychiatry; 2005 Sep; 58(5):364-73. PubMed ID: 16139582
[TBL] [Abstract][Full Text] [Related]
5. P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder.
Neuhaus AH; Luborzewski A; Rentzsch J; Brakemeier EL; Opgen-Rhein C; Gallinat J; Bajbouj M
J Affect Disord; 2007 Jun; 100(1-3):123-8. PubMed ID: 17098290
[TBL] [Abstract][Full Text] [Related]
6. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
7. Surgically restoring portal blood flow to the liver in children with primary extrahepatic portal vein thrombosis improves fluid neurocognitive ability.
Mack CL; Zelko FA; Lokar J; Superina R; Alonso EM; Blei AT; Whitington PF
Pediatrics; 2006 Mar; 117(3):e405-12. PubMed ID: 16481447
[TBL] [Abstract][Full Text] [Related]
8. Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.
Fabre I; Galinowski A; Oppenheim C; Gallarda T; Meder JF; De Montigny C; Olié JP; Poirier MF
Int J Geriatr Psychiatry; 2004 Sep; 19(9):833-42. PubMed ID: 15352140
[TBL] [Abstract][Full Text] [Related]
9. Clinical issues in considering vagus nerve stimulation for treatment-resistant depression.
Rush AJ; Siefert SE
Exp Neurol; 2009 Sep; 219(1):36-43. PubMed ID: 19397908
[TBL] [Abstract][Full Text] [Related]
10. Vagus nerve stimulation (VNS) for treatment-resistant depression: efficacy, side effects, and predictors of outcome.
Sackeim HA; Rush AJ; George MS; Marangell LB; Husain MM; Nahas Z; Johnson CR; Seidman S; Giller C; Haines S; Simpson RK; Goodman RR
Neuropsychopharmacology; 2001 Nov; 25(5):713-28. PubMed ID: 11682255
[TBL] [Abstract][Full Text] [Related]
11. Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Rush AJ; Marangell LB; Sackeim HA; George MS; Brannan SK; Davis SM; Howland R; Kling MA; Rittberg BR; Burke WJ; Rapaport MH; Zajecka J; Nierenberg AA; Husain MM; Ginsberg D; Cooke RG
Biol Psychiatry; 2005 Sep; 58(5):347-54. PubMed ID: 16139580
[TBL] [Abstract][Full Text] [Related]
12. Successful computer-assisted cognitive remediation therapy in patients with unipolar depression: a proof of principle study.
Elgamal S; McKinnon MC; Ramakrishnan K; Joffe RT; MacQueen G
Psychol Med; 2007 Sep; 37(9):1229-38. PubMed ID: 17610766
[TBL] [Abstract][Full Text] [Related]
13. VNS and depression: current status and future directions.
Walsh SP; Kling MA
Expert Rev Med Devices; 2004 Sep; 1(1):155-60. PubMed ID: 16293018
[TBL] [Abstract][Full Text] [Related]
14. Changes in hypothalamic-pituitary-adrenal axis measures after vagus nerve stimulation therapy in chronic depression.
O'Keane V; Dinan TG; Scott L; Corcoran C
Biol Psychiatry; 2005 Dec; 58(12):963-8. PubMed ID: 16005439
[TBL] [Abstract][Full Text] [Related]
15. Vagus nerve stimulation for depression: efficacy and safety in a European study.
Schlaepfer TE; Frick C; Zobel A; Maier W; Heuser I; Bajbouj M; O'Keane V; Corcoran C; Adolfsson R; Trimble M; Rau H; Hoff HJ; Padberg F; Müller-Siecheneder F; Audenaert K; Van den Abbeele D; Stanga Z; Hasdemir M
Psychol Med; 2008 May; 38(5):651-61. PubMed ID: 18177525
[TBL] [Abstract][Full Text] [Related]
16. Right-sided vagus nerve stimulation as a treatment for refractory epilepsy in humans.
McGregor A; Wheless J; Baumgartner J; Bettis D
Epilepsia; 2005 Jan; 46(1):91-6. PubMed ID: 15660773
[TBL] [Abstract][Full Text] [Related]
17. Attention and executive functions in remitted major depression patients.
Paelecke-Habermann Y; Pohl J; Leplow B
J Affect Disord; 2005 Dec; 89(1-3):125-35. PubMed ID: 16324752
[TBL] [Abstract][Full Text] [Related]
18. Effect of vagus nerve stimulation on cerebrospinal fluid monoamine metabolites, norepinephrine, and gamma-aminobutyric acid concentrations in depressed patients.
Carpenter LL; Moreno FA; Kling MA; Anderson GM; Regenold WT; Labiner DM; Price LH
Biol Psychiatry; 2004 Sep; 56(6):418-26. PubMed ID: 15364040
[TBL] [Abstract][Full Text] [Related]
19. Concomitant use of vagus nerve stimulation and electroconvulsive therapy for treatment-resistant depression.
Burke MJ; Husain MM
J ECT; 2006 Sep; 22(3):218-22. PubMed ID: 16957540
[TBL] [Abstract][Full Text] [Related]
20. Effect of Sahaj Yoga on neuro-cognitive functions in patients suffering from major depression.
Sharma VK; Das S; Mondal S; Goswami U; Gandhi A
Indian J Physiol Pharmacol; 2006; 50(4):375-83. PubMed ID: 17402267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
